269 related articles for article (PubMed ID: 21999894)
1. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.
Rosales RL; Kanovsky P; Fernandez HH
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S3-10. PubMed ID: 21999894
[TBL] [Abstract][Full Text] [Related]
2. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
3. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in poststroke spasticity.
Ozcakir S; Sivrioglu K
Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
10. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
[TBL] [Abstract][Full Text] [Related]
12. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
Teasell R; Foley N; Pereira S; Sequeira K; Miller T
Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
[TBL] [Abstract][Full Text] [Related]
13. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A
Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
[TBL] [Abstract][Full Text] [Related]
15. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
[TBL] [Abstract][Full Text] [Related]
16. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
18. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P
Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045
[TBL] [Abstract][Full Text] [Related]
19. [Spasticity and botulinum toxin in 2003. An update].
Fève A
Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
